糖尿病白内障超声乳化及人工晶状体植入术58例

Phacoemulsification and intraocular lens implantation on diabetes cataract patients

目的探讨糖尿病患者血糖控制在12 mmol/L以下,颞侧透明角膜切口白内障超声乳化及人工晶状体植入术的临床效果。方法对糖尿病白内障患者58例（72眼）施行颞侧透明角膜切口白内障超声乳化及人工晶状体植入术,观察手术并发症及术后视力、切口愈合情况。结果随访1年,裸眼或矫正视力≤0.1者2眼（2.78%）,0.1-0.3者1眼（1.39%）,0.3-0.5者2眼（2.78%）,0.8-1.5者67眼（93.06%）。术中无出血,术后无感染,切口愈合良好。结论糖尿病白内障患者餐后血糖控制在12 mmol/L以下者,于表面麻醉下行白内障超声乳化及人工晶状体植入术是安全可行的。

Objective To discuss clinical therapeutic effectiveness of phacoemulsification and intraocular lens（IOL） implantation through temporal transparent cornea glucose incision technique on diabetic cataract patients controlling their blood glucose less than 12mmol/L.MethodsPhacoemulsification and IOL implantation was performed by temporal transparent cornea incision of diabetic cataract patients on 72 eyes of 58 cases.The postoperative complications,visual acuity and cut scar over circumstances were observed.ResultsAt later visiting for 1 year,naked eye or correct defects of vision was less than 0.1 in 2 eyes（2.78%）,0.1 to 0.3 in 1 eye（1.39%）,0.3 to 0.5 in 2 eyes（2.78%）,0.8 to 1.5 in 67 eyes（93.06%）.There was no bleeding during intraoperative and no infection after operative.Conclusion Phacoemulsification and IOL implantation is safe and reliable on diabetic cataract patients controlling their postprandial blood glucose less than 12mmol/L.